Barely Significant
← all phrases

“may be significant”

13,098 sentences · 13,098 papers · 69,431 search hits before verification

In the literature

r negligible, inhomogeneous contributions from g strain, D strain, and/or unresolved superhyperfine splittings, but possibly with finite contributions from E strain; Contributions to the linewidth from dipolar interactions are negligible under the assumption of the point-dipole model, however, they may be significant under a spatial dipole model; Spin-lattice relaxation includes a thus far rarely encountered inverted Orbach mechanism, which–contrary to regular Orbach relaxation–is virtually temperature-independent; At temperatures below 150 K, the X 2 resonance continues to sharpen but the Y 2 resonance re-broa
Looking at our unsupervised attributions shows that while there may be significant enough differences in expression of genes in the “IFN Gamma Signaling” pathway to differentiate stimulated and unstimulated cells, this pathway is not one of the major sources of variation in the dataset, at least when compared to pathways more directly related to IFN- \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\beta$$\end{document} β signaling.
The research findings were as follows: (1) plasma MIF levels were elevated in SCI patients compared to that of in normal controls; (2) MIF levels in plasma were related to SCI severity based on ASIA; (3) higher plasma MIF were related to elevated risk of DVT in the follow-up of 1 month, for each additional 1ng/mL of MIF, the DVT risk before and after adjustment was increased by 11% and 8%, respectively; (4) MIF plasma levels at admission may be significant in predicting DVT of SCI patients.
As already discussed, patient characteristics, particularly in regard to BMI and the prevalence of diabetes, may be significant sources of heterogeneity when comparing the prevalence of steatohepatitis between studies. 36 In the studies of Gomez-Ramirez et al. 30 and Pawlik et al., 31 both of which reported a positive association between steatohepatitis and irinotecan, patients receiving irinotecan were more likely to have a higher mean BMI (29.3 vs. 26.2 and 28.1 vs. 26.6 kg/m 2 , respectively).
There may be significant administration costs, as well as print and shipping costs of trial materials related to the recruitment and the follow‐up of randomised participants lost to follow‐up, acting as resource misallocation to the trial commissioner's budget of £722,096.59 (NIHR Health Technology Assessment Programme 14/49/149). 7 A CONSORT diagram showing the recruitment and retention of participants in the OTIS trial is available in Supporting Information 1 . 1.3.